New Zealand-based virtual reality and cognitive behavioral therapy company oVRcome announced it signed an international contract with the U.K.'s National Health Service (NHS) to help autistic individuals navigate hospital environments and social interactions.
oVRcome, launched in 2021, utilizes a smartphone and a headset to deliver exposure therapy to adults and children with numerous conditions...
Virtual reality (VR) behavioral therapy platform Floreo closed a $10 million Series A funding round led by Tenfore Holdings with participation from Autism Impact Fund, Disability Opportunity Fund and Felton Group.
The funding comes on the heels of a Category III Current Procedural Terminology Code (CPT) from the American Medical Association for the use of VR technology to assist with therapy....
A clinical trial in New Zealand found a virtual reality app-based cognitive behaviour therapy programme reduced the symptoms of common phobias.
FINDINGS
Conducted between May and December last year, the randomised, controlled trial recruited a total of 129 adult participants with fears of flying, heights, needles, spiders and dogs. It was led by Dr Cameron Lacey, associate professor from the...
![[Left] Adam Hutchinson, founder of oVRcome, and [Right] Dr Cameron Lacey of the University of Otago](https://www.mobihealthnews.com/sites/default/files/styles/230x130/public/1630195915719.jpg?itok=Kolmo1bB)
